The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Perspective designed [212Pb]VMT-α-NET to target and deliver 212Pb to tumor sites expressing somatostatin receptor type 2 (SSTR2). The Company is conducting a multi-center, open-label, dose-escalation, ...
SEATTLE, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN ...
Please provide your email address to receive an email when new articles are posted on . More optometrists are managing and comanaging glaucoma, cataract and retina patients, and advances in the areas ...
Perspective Therapeutics, Inc. (CATX) is working on developing one of its lead drugs known as VTM-a-NET for the treatment of patients with unresectable or metastatic somatostatin receptor type 2 ...
A Washington think tank is encouraging the federal government to proceed with a legislatively mandated national pilot program to explore the viability of a vehicle-miles-traveled fee, a system viewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results